Topical JAK Inhibitor Shows Itch Relief in Prurigo Nodularis Trial
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
Patients treated with a topical JAK inhibitor experienced significant reductions in itch as early as day 7 and greater treatment success by week 12.
The latest version features increased energy output, interchangeable spot sizes, and system upgrades aimed at enhancing multi-modal aesthetic treatments.